🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Although hip replacement surgery is a successful way of dealing with the pa...
Status
Completed
Location
Academic Unit of Bone Metabolism
Start Date
2011-12-14
Trial ID
NCT01358669
This is a 2-year study to evaluate the effect of denosumab versus risedrona...
Status
Completed
Location
Research Site
Start Date
2012-03-28
Trial ID
NCT01575873
Treatments Being Tested
The main objective is to study the efficacy of denosumab in reducing wear-i...
Status
Unknown
Location
Danderyd Hospital
Start Date
2015-08
Trial ID
NCT02299817
This is a phase 2 study of the drug denosumab for the management bone metas...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2018-09-04
Trial ID
NCT03520231
Treatments Being Tested
The primary objective of this study is to assess the effect of AMG 162 (den...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00306189
Treatments Being Tested
The Bone Zone trial is a prospective, multi-centre, double-blind, phase II,...
Status
Recruiting
Location
St Vincent's Health Sydney
Start Date
2021-07-15
Trial ID
NCT04608630
This is a randomized, double-blind, parallel-group, placebo-controlled, sin...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2018-01-10
Trial ID
NCT03427853
Studies objectives: To evaluate the safety, tolerability and efficacy of A...
Status
Withdrawn
Location
Soroka Medical Center
Start Date
2022-06
Trial ID
NCT02864784
Treatments Being Tested
The purpose of this study is to determine whether in postmenopausal women w...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00330460
Treatments Being Tested
The purpose of this study is to determine if denosumab is effective in incr...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11
Trial ID
NCT01457950
Treatments Being Tested